ASHE ANDREW D. (See Remarks) sold 0.8% of their position (2.68K shares) of VERVE THERAPEUTICS, INC. on the open market
Open‑market sale worth $11.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2025ACC: 0000950170-25-050561
Officer· See Remarks
Since Jun 2021
-2.68K
Net shares
Net seller
$11.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9K acquired · 11.68K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9K
Price / share
—
Trade value
—
% of position
2.6%
4/1/2025
342.51K→351.51K
Common Stock
Direct
Shares
−2.68K
Price / share
$4.15
Trade value
$11.13K
% of position
0.8%
4/2/2025
351.51K→348.83K
Total
Net shares
+6.32K
Net value
-$11.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2025 | M · Option Exercise | +9K | — | — | 2.6% | 342.51K | 351.51K |
| Common Stock Direct | 4/2/2025 | S · Sale | −2.68K | $4.15 | $11.13K | 0.8% | 351.51K | 348.83K |
| Total | +6.32K | -$11.13K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
9K shares
Shares
−9K
Strike price
Held after
27K
Exercisable
—
4/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock9K shares | 4/1/2025 | M · Option Exercise | −9K | — | 27K |